Increasing Demand for Advanced Technologies to Foster the Growth of DevOps Market by 2027 – Exclusive Report [207 pages] by Research Dive

PUNE, India, Nov. 30, 2020 /PRNewswire/ –The global DevOps market is predicted to observe a significant growth in forecast period due to the growing demand advanced technologies for optimizing business operations. The North America region to subjugate the industry by 2027.

Research Dive

As per a Research Dive latest report, the Global DevOps Market is anticipated to grow at a CAGR of 22.9% and generate a revenue of $23,362.8 million during the forecast period from 2020 to 2027. The North America DevOps market is projected to account for the majority of revenue share over the forecast period. This is majorly because U.S. and Canada are major contributors for DevOps platforms and the presence of large number of key players in the region.

Request to Download Sample Report Copy of DevOps Market: https://www.researchdive.com/download-sample/2801

Market Dynamics

The growing demand for advanced technologies to enhance business operations and the rising adoption of DevOps platforms by enterprises are the major factors predicted to fuel the growth of the global DevOps market by the end of 2027. Moreover, the continuous technological advancements in DevOps are likely to create enormous opportunities for the global market growth in the coming years. Conversely, the dearth of skilled workforce and high associated with advanced DevOps systems are expected to hamper the market growth by 2027.

Additionally, the COVID-19 pandemic has amplified the growth of the global DevOps market, due to the growing significance of cloud platforms and systems for enhancing business growth through digital transformation. Besides, enterprises around the world are implementing digital transformations services to resume & sustain their business in the pandemic crisis.

Get Access to COVID-19 Impact Analysis on DevOps Market: https://www.researchdive.com/connect-to-analyst/2801

Key Segment Findings of the Market:

The report segments the global DevOps market into Solution, Deployment Type, End-User, and Region.

  • By solution, the monitoring & performance segment is expected to garner $6,410.3 million and subjugate the global industry by 2027. This is majorly owing to extensive utilization of DevOps tools for full stack performance management and monitoring of infrastructure including cloud networks, app & web servers, databases, and others.
  • By deployment type, the cloud segment valued for $2,944.2 million in 2019 and projected to witness a significant growth over the forecast period. Growing demand for software automations is the major actor likely to propel the segmental market growth by the end of 2027.
  • By end-user, the small & medium enterprises (SMEs) segment valued for $2,292.1 million in 2019 and is predicted to hold noteworthy share in the global market by 2027. This is due to the rising adoption of DevOps platforms by SME’s in software optimization & development services.
  • Geographically, the overall industry is divided into Asia Pacific, North America, LAMEA, and Europe. The Asia Pacific region is expected to grow at a significant rate by 2027.

Top 10 Players in DevOps Market

The major players of the global DevOps market are

  1. Alphabet
  2. Micro Focus
  3. Microsoft
  4. Broadcom
  5. Hewlett Packard Enterprise Development LP
  6. Alibaba Group Holding Limited
  7. Cigniti
  8. Amazon Web Services, Inc.
  9. IBM
  10. Oracle.

Further, the report outlines and presents several aspects of these key players such as financial performance, SWOT analysis, recent strategic moves & developments, and product portfolio. – Inquire and Get Quick Access to Top Companies Development Strategies Summary Report [80 pages]

These players are emphasizing more on mergers, acquisitions, partnerships, and technological advancements to obtain a strong position in the global industry. For instance, in July 2019, DBmaestro and IBM Corporation entered into a global strategic partnership on DevOps and cloud solutions. The aim of this partnerships was to execute the latter’s database release automation competences and improve its DevOps environments for various enterprises.

More About DevOps:

What are the 10 Most Popular DevOps Used in today’s Time?

DevOps Industry Growth Surges with the Rising Need for Efficient Business Operations

Some Trending Topics:

1.  Pipeline Security Market: Global Opportunity Analysis and Industry Forecast, 2019–2026 – Request to Download Sample Report

2.  Artificial Intelligence in Agriculture Market: Global Opportunity Analysis and Industry Forecast, 2019–2026 – Request to Download Sample Report

3.  Natural Language Processing (NLP) in Healthcare and Life Sciences Market: Global Opportunity Analysis and Industry Forecast, 2019–2026 – Request to Download Sample Report

4.  Low Code Development Platform Market: Global Opportunity Analysis and Industry Forecast, 2019–2024.- Request to Download Sample Report

About Research Dive

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York NY 10005
(P) +91-(788)-802-9103 (India)
+1-(917)-444-1262 (US)
Toll Free: 1-888-961-4454
E-mail: support@researchdive.com
Website: https://www.researchdive.com
Blog:  https://www.researchdive.com/blog/
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521

Cision View original content:http://www.prnewswire.com/news-releases/increasing-demand-for-advanced-technologies-to-foster-the-growth-of-devops-market-by-2027–exclusive-report-207-pages-by-research-dive-301181511.html

SOURCE Research Dive

Amesite to Present at Upcoming Investor Conferences

ANN ARBOR, Mich., Nov. 30, 2020 /PRNewswire/ — Amesite Inc. (Nasdaq: AMST), an artificial intelligence software company providing online learning ecosystems for business, higher education, and K-12, announced today its Founder & CEO, Dr. Ann Marie Sastry, will present to the investment community at the following virtual events:

B. Riley Securities Education Services & Technology Conference
Wednesday, December 2, 2020 at 9:30 a.m. ET
To register for the live broadcast of the virtual event:
https://us02web.zoom.us/webinar/register/WN_o4XKoIrPRJ6_2nrQmjdXhQ

Benzinga Global Small Cap Conference
Tuesday, December 8, 2020 at 1:45 p.m. ET
To register for the live broadcast of the virtual event:
https://events.benzinga.com/registration-page?gclid=CjwKCAiAnvj9BRA4EiwAuUMDf-TCcVLGmiwskcnfvCNVpsa3ZkUeMz9vfuXOd4y2BZ60DmlH1U_GHhoCvlMQAvD_BwE

Amesite’s innovative cloud-based platform delivers learning, branded to its customers and compatible with customers’ existing systems. Amesite uses AI to provide unparalleled engagement and ease of use, with a fully integrated experience on a single, turnkey and scalable system.

About Amesite Inc.
Amesite is a high-tech artificial intelligence software company offering a cloud-based platform and content creation services for K-12, college, university and business education and upskilling. For more information, visit https://amesite.com.

Forward Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company’s planned online machine learning platform, the Company’s business plans, any future commercialization of the Company’s online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company’s filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: Bob Prag
858-794-9500
bprag@delmarconsulting.com

Cision View original content:http://www.prnewswire.com/news-releases/amesite-to-present-at-upcoming-investor-conferences-301181328.html

SOURCE Amesite, Inc.

Vendor-Neutral Advanced Visualization Platform Enables Powerful Technology for Covid-19 Analysis

NEWARK, Calif., Nov. 30, 2020 /PRNewswire-PRWeb/ — Ziosoft, a pioneer in 3D/4D AI medical visualization, is featuring its comprehensive suite of advanced visualization and post-processing applications, on a true vendor neutral platform, at RSNA’s virtual 2020 exhibition being held November 29December 5. Featured this year on the company’s flagship Ziostation2 system are a wide-range of applications, which are well suited in the analysis of pathology caused by the Covid-19 virus as the disease affects multiple anatomy, such as respiratory, pulmonary and cardiovascular sites.

Several studies published earlier this year indicate Covid-19 specifically can cause myocardial injury or heart failure in up to 20 – 24 percent of affected patients. Two of these studies found that between 49-52 percent of patients who died from the disease experienced heart failure.

“In addition to respiratory and pulmonary impact, these recent studies demonstrate significant cardiac injury risk as well,” said Rajeev Taitriya, vice president of Business Development and Marketing, Ziosoft. “Our Ziostation2 software provides numerous tools for analyzing these symptoms including pulmonary analysis, virtual bronchoscopy, CT cardiac function and MR coronary analysis, in addition to several other visualization and measurement solutions. All are designed to provide comprehensive analysis capabilities to help support diagnostic confidence and help guide therapeutic endeavors.”

Ziosoft’s platform provides a robust and clinically validated algorithm, which is driven by both a traditional and new era of machine learning, unlocking the potentials of artificial intelligence (AI) for efficient and repeatable outcomes. The company’s flagship Ziostation2 is an economical and scalable multi-departmental solution. A full suite of regulatory cleared 2D, 3D, and 4D analytical tools provides consistent functionality across the enterprise, without compromise.

With over 3,000 installations in 2,000 locations throughout more than 30 countries globally, the company is also highlighting PhyZiodynamics™ in Vivo, which enables virtual dynamic dissection to support precise therapy for organ targeting analyses and Implantations. PhyZiodynamics in Vivo offers an unprecedented “real-time” journey through the body non-invasively, supporting diagnoses and treatment planning for numerous anatomical targets.

“These unprecedented times call for highly sophisticated and comprehensive solutions for imaging visualization and analysis,” said Shusuke Chino, co-founder and president, Ziosoft. “We use 20 plus years of medical imaging expertise with deep learning to enable accurate segmentation with easy-to-use intuitive tools for efficient and customizable workflows. This experience has not only brought outstanding 3D/4D to the radiological community, but several other useful tools to support clinicians during this challenging period.”

Media Contact

Laurie Hallwyler, ckj Communications, +1 (650) 248-9081, laurie@ckjcomm.com

 

SOURCE Ziosoft

CerraCap Ventures and Exfinity Venture Partners join forces for New Growth

COSTA MESA, Calif., Nov. 30, 2020 /PRNewswire/ — CerraCap Ventures and Exfinity Venture Partners are pleased to announce their global strategic partnership integrating CerraCap’s unique Sales & Scale model with Exfinity’s stated vision helping develop global enterprise startups leveraging the Indo-US corridor. 

CerraCap and Exfinity together are poised to unleash the next wave of enterprise artificial intelligence and digital disruption. “With Exfinity’s understanding of complex digital product interactions, its deep engineering expertise and agile collaborative approach uniquely compliments how CerraCap operates. We believe this facilitates an extraordinary opportunity for expansion of right global investments for leading technology products and platform,” shared Saurabh Ranjan, CEO and Founder, CerraCap Ventures. 

Given that CerraCap is domiciled in US and Exfinity in India, portfolio companies will benefit the Indo-US corridor for optimum capital and access to the global markets. Enterprise startups can leverage the CerraCap-Exfinity partnership to create frugal but cutting-edge innovation in India and launch the products in US. Together their core investment will focus on Cyber Security, Health-Tech, Logistics, Document Intelligence, Computer Vision, and Machine Learning which incorporates deep learning and underpins many recent advances in other AI technologies.

“Partnering with CerraCap Ventures will allow us to provide the very best business program and portfolio strategies on which we will conceive, design, and build the next generation of transformative enterprise and digital products and platforms,” said Shailesh Ghorpade, Managing Partner & CIO of Exfinity. “Together, working as one team, we will unlock the full potential of enterprise AI and place our portfolio companies on the best path for their success in the new ever changing business landscape.”

CERRACAP VENTURES is a Global fund headquartered in Orange County, California dedicated to early-stage technology investments in enterprise (B2B) solutions focused on the new fundamentals of the digital age – Healthcare, Enterprise AI and Cyber Security. It enables rapid growth of technology startups leveraging its unique Sales & Scale™ business model, driving revenue from large enterprises into its portfolio companies. 

EXFINITY VENTURE PARTNERS is an early-stage Venture Capital Fund based out of India and registered with SEBI as a Category I AIF. It is founded by industry veterans who have strong operating backgrounds. The fund focuses on Enterprise Tech investments at pre–Series A, Series A stage. Exfinity is now raising its third fund with a targeted size of INR 5 billion.

For media enquiries, please contact:
Email: na@cerracap.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cerracap-ventures-and-exfinity-venture-partners-join-forces-for-new-growth-301181381.html

SOURCE CerraCap Ventures

INDUS.AI launches new Autodesk BIM 360 integration to improve construction project productivity and safety

SAN FRANCISCO, Nov. 30, 2020 /PRNewswire/ — Today INDUS.AI, the leader in artificial intelligence powered construction performance and safety monitoring, announced a new integration with Autodesk Construction CloudTM, enabling customers to easily access their INDUS.AI monitoring and insights dashboard on their BIM 360® project home page via a Partner Card.

As opposed to having users manually filling in daily progress information, INDUS.AI uses computer vision to automatically capture video streams and time-lapse images from the jobsite and deliver performance analysis. The INDUS.AI platform identifies risks and provides actionable insights, saving construction managers time and providing them with real-time visibility into jobsite activities, subcontractor coordination and production progress. The visibility improves transparency and decreases schedule risk by helping teams stay ahead of potential issues. The INDUS.AI and – BIM 360 integration reduces teams’ administrative burden and supervisory resources on construction projects.

“Our customers have been discovering how our autonomous monitoring technology can cut labor costs, improve safety and reduce their risk on construction projects. With this new BIM 360 integration, they can now gain insights and remotely manage into their production performance and safety of their projects directly in Autodesk Construction Cloud,” said Matt Man, CEO of INDUS.AI. “Our customers are busy professionals, and we are thrilled to make it easier for them to stay on top of critical events on their projects.”

“Given the size and complexity of construction projects, teams and managers need a comprehensive digest of project information, including what’s happening on-site, in one place,” said James Cook, head of integrations at Autodesk Construction Solutions. “Adding INDUS.AI’s real-time visual analysis tool to BIM 360 will help customers understand what’s happening on their jobsites so they can stay informed and aware of progress and issues to enhance their productivity.”

Learn more about INDUS.AI’s latest integration by searching Autodesk Construction Cloud Integrations App Marketplace.

About INDUS.AI

INDUS.AI’s construction intelligence solution enables real estate investors, owners, developers, and general contractors to have real-time visibility and actionable insights into all activities, productivity, and risks at their construction sites. INDUS.AI seeks to make construction sites and projects safer, more efficient and completely transparent.

Autodesk, Autodesk Construction Cloud and BIM 360 are registered trademarks or trademarks of Autodesk, Inc., in the USA and/or other countries.

 

Cision View original content:http://www.prnewswire.com/news-releases/indusai-launches-new-autodesk-bim-360-integration-to-improve-construction-project-productivity-and-safety-301181931.html

SOURCE INDUS.AI

View, the leader in Smart Windows, to Merge with CF Finance Acquisition Corp. II

MILPITAS, Calif. and NEW YORK, Nov. 30, 2020 /PRNewswire/ — View, Inc. (“View”), a Silicon Valley-based smart window company, and CF Finance Acquisition Corp. II (Nasdaq: CFII) (“CF II”), a special purpose acquisition company sponsored by Cantor Fitzgerald, today announced they have entered into a definitive merger agreement. The combined company will be called View, Inc. and will be publicly listed on the NASDAQ market following the close of the transaction.

View is the market leader in next-generation smart windows that use artificial intelligence and machine learning which will tint the glass to optimize natural light while controlling heat and glare to enhance mental and physical well-being for occupants, creating smart connected buildings which reduce energy consumption and greenhouse gas (GHG) emissions.

View serves diverse real estate segments including corporate office, airports, multifamily, education, and healthcare. Strong secular tailwinds of climate change, human health and smart buildings are driving demand for View’s smart windows. Environmental, social and governance initiatives and growing government regulations require buildings to retrofit and become energy efficient and net-zero-energy dwellings.

Following the closing of the transaction, View Chairman and CEO, Dr. Rao Mulpuri, and CFO, Vidul Prakash, will continue to lead View, supported by a deep and talented management team with substantial experience scaling high-growth businesses.

Dr. Mulpuri stated, “Climate change and human health are two of the most important challenges and opportunities of our time, and View is well-positioned to use technology to drive change across the real estate industry. View has created groundbreaking products, covered by over 1,000 patents and built state of the art manufacturing operations in the United States.  As we become a public company and continue on our growth strategy, we are very excited to partner with Howard Lutnick and the team at Newmark, which will enable us to leverage their deep commercial real estate expertise.”

Howard Lutnick, Chairman and CEO of Cantor Fitzgerald, CF Finance Acquisition Corp. II, and Chairman of Newmark Group, stated, “View’s smart windows are a gamechanger that will revolutionize the real estate experience.  Buildings will no longer need blinds and shades, which will enhance the experience of building occupants, substantially reduce energy usage, and improve space utilization. We are excited to be working with Rao and the team at View to not only help deliver the capital needed to further build out View’s capacity, but also leverage our real estate platforms to create awareness, scale and drive change across the real estate industry.”

Transaction Details
The Board of Directors of each of View and CF Finance Acquisition Corp. II have unanimously approved the transaction. The transaction will require the approval of the stockholders of CF Finance Acquisition Corp. II and View, and is subject to other customary closing conditions, including the receipt of certain regulatory approvals. The transaction is expected to close in the first quarter of 2021.

Assuming no redemptions by CF II stockholders, the transaction is expected to deliver up to $800 million of gross proceeds including the contribution of up to $500 million of cash held in CFII’s trust account from its initial public offering. The transaction is further supported by a $300 million private investment in public equity (“PIPE”) at $10.00 per share.

All cash remaining in CF II at the closing after paying off transaction expenses and CF II liabilities is expected to be used to retire debt and to add cash to View’s balance sheet for working capital, growth capex and other general corporate purposes.

Advisors
Goldman Sachs & Co. LLC is acting as exclusive financial advisor to View. Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal advisor to View.

Cantor Fitzgerald & Co. is acting as financial and capital markets advisor to CF II.  Hughes Hubbard & Reed LLP and Ellenoff Grossman & Schole LLP are acting as legal advisors to CF II.

Cantor Fitzgerald & Co. and Goldman Sachs & Co. LLC served as placement agents for the PIPE financing.

Investor video and management presentation will be made available at https://view.com/investor-relations. The management presentation and a transcript of the investor video will be filed with the U.S. Securities and Exchange Commission (the “SEC”) as an exhibit to a Current Report on Form 8-K, and available on the SEC website at www.sec.gov.

About View
View is a technology company creating smart and connected buildings to improve people’s health and wellness, while simultaneously reducing energy consumption. View is also the market leader in smart windows that let in natural light and views and enhance mental and physical well-being by reducing headaches, eyestrain and drowsiness. Every View installation includes a ‘smart building platform’ that consists of power, network and communication infrastructure. For more information, please visit: view.com

About CF Finance Acquisition Corp. II     
CF Finance Acquisition Corp. II is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. CF II’s efforts to identify a prospective target business are not limited to a particular industry or geographic region, but CF II intends to focus on industries where its management team and founders have experience, including the financial services, healthcare, real estate services, technology and software industries. CF Finance Acquisition Corp. II is led by Chairman and Chief Executive Officer Howard W. Lutnick.

About Cantor Fitzgerald
CF II is sponsored by Cantor Fitzgerald.  Cantor Fitzgerald, with over 12,000 employees, is a leading global financial services group at the forefront of financial and technological innovation and has been a proven and resilient leader for over 70 years. Cantor Fitzgerald & Co. is a preeminent investment bank serving more than 5,000 institutional clients around the world, recognized for its strengths in fixed income and equity capital markets, investment banking, prime brokerage, and commercial real estate and for its global distribution platform. Cantor Fitzgerald & Co. is one of the 24 primary dealers authorized to transact business with the Federal Reserve Bank of New York. For more information, please visit: www.cantor.com.

Important Information and Where to Find It
This press release relates to a proposed transaction between CF II and View. This press release does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. In connection with the transaction described herein, CF II intends to file relevant materials with the SEC, including a registration statement on Form S-4, which will include a proxy statement/prospectus. The proxy statement/prospectus will be sent to all CF II stockholders. CF II also will file other documents regarding the proposed transaction with the SEC. Before making any voting or investment decision, investors and security holders of CF II are urged to read the registration statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC in connection with the proposed transaction as they become available because they will contain important information about the proposed transaction.

Investors and security holders will be able to obtain free copies of the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC by CF II through the website maintained by the SEC at www.sec.gov or by directing a request to CF II to 110 East 59th Street, New York, NY 10022 or via email at CFFinanceII@cantor.com or at (212) 938-5000.

Participants in the Solicitation
CF II and View and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from CF II’s stockholders in connection with the proposed transaction. Information about CF II’s directors and executive officers and their ownership of CF II’s securities is set forth in CF II’s filings with the SEC. Additional information regarding the interests of those persons and other persons who may be deemed participants in the proposed transaction may be obtained by reading the proxy statement/prospectus regarding the proposed transaction when it becomes available. You may obtain free copies of these documents as described in the preceding paragraph.

Non-Solicitation
This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential transaction and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of CF II or View, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act.

Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as  “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by an investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of CF II and View. Many factors could cause actual future events to differ from the forward-looking statements in this press release, including but not limited to: (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect the price of CF II’s securities, (ii) the risk that the transaction may not be completed by CF II’s business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by CF II, (iii) the failure to satisfy the conditions to the consummation of the transaction, including the approval by the stockholders of CF II, the satisfaction of the minimum trust account amount following any redemptions by CF II’s public stockholders and the receipt of certain governmental and regulatory approvals, (iv) the inability to complete the PIPE Investments, (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement, (vi) the effect of the announcement or pendency of the transaction on View’s business relationships, operating results, and business generally, (vii) risks that the transaction disrupt current plans and operations of View and potential difficulties in View employee retention as a result of the transaction, (viii) the outcome of any legal proceedings that may be instituted against View or against CF II related to the merger agreement or the transaction, (ix) the ability to maintain the listing of CF II stock on the Nasdaq Stock Market, (x) volatility in the price of CF II’s securities, (xi) changes in competitive and regulated industries in which View operates, variations in operating performance across competitors, changes in laws and regulations affecting View’s business and changes in the combined capital structure, (xii) the ability to implement business plans, forecasts, and other expectations after the completion of the transaction, and identify and realize additional opportunities,(xiii) the potential inability of View to increase its manufacturing capacity or to achieve efficiencies regarding its manufacturing process or other costs, (xiv) the enforceability of View’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others, (xv) the risk of downturns and a changing regulatory landscape in the highly competitive industry in which View operates, and (xvi) costs related to the transaction and the failure to realize anticipated benefits of the transaction or to realize estimated pro forma results and underlying assumptions, including with respect to estimated stockholder redemptions. These risks and uncertainties may be amplified by the COVID-19 pandemic, which has caused significant economic uncertainty. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of CF II’s Quarterly Reports on Form 10-Q, the registration statement that includes a proxy statement/prospectus on Form S-4 and other documents filed by CF II from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and View and CF II assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Neither View nor CF II gives any assurance that either View or CF II will achieve its expectations.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/view-the-leader-in-smart-windows-to-merge-with-cf-finance-acquisition-corp-ii-301181897.html

SOURCE View, Inc.; CF Finance Acquisition Corp. II

Momentum Continues for Visage at RSNA 2020

SAN DIEGO, Nov. 30, 2020 /PRNewswire/ — Visage Imaging, Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will be showcasing the latest version of the Visage® 7 Enterprise Imaging Platform, featuring the introduction of Visage 7 Live Connect (as a works-in-progress), at the virtual Radiological Society of North America (RSNA) 2020 annual meeting, from Sunday, November 29Saturday, December 5, 2020.

Visage 7 Live Connect empowers collaboration, making real-time communications easy.

Visage has proven especially resilient during the global pandemic. The company’s leading-edge technology enables radiologists to read remotely with lightning-fast speed and diagnostic precision regardless of the size or type of examination(s). Go-lives for both on-premise and public-cloud based implementations have continued throughout, underpinned by the company’s ability to provide remote training and support regardless of the scale or complexity of the implementation. This has further strengthened Visage’s reputation for seamless replacement of legacy PACS.

Healthcare institutions are seeking modern, flexible solutions and have a heightened awareness of security due to the increasing threat of malware and ransomware attacks. These factors, in combination with the relentless growth of imaging datasets, continue to present architectural and performance hurdles for imaging organizations reliant on legacy PACS with ‘compress and send’ limitations and inferior server-side technology.

“Today’s Enterprise Imaging challenges institutions with constantly evolving requirements,” explained Malte Westerhoff, PhD, Visage Imaging Co-Founder and Chief Technology Officer. Dr. Westerhoff continued, “At Visage, we continue to implement leading design principles with Visage 7 that enhance capabilities, improve performance and tighten security. This allows our customers to remain a step ahead of their increasing clinical needs and the threats that they must navigate. Visage continues to innovate with significant velocity, rapidly getting new features into clinical use. With Visage 7 Live Connect, we’re enabling radiologists to easily share images with referring physicians during interpretation, without disruption to diagnostic reading workflow. The simplicity of collaboration will encourage radiologists to utilize imaging communications in ways that were previously not thought possible, to include the potential for collaboration with patients and their imaging.”

At RSNA 2020, the following highlights will be demonstrated and discussed:

  • Visage 7 Live Connect. Visage 7 Live Connect empowers collaboration, making real-time communications easy. Radiologists will be able to immediately and securely collaborate, sharing images with referrers directly from Visage 7 during interpretation workflow. The radiologist will simply pass a secure link and session code to all intended recipients for real-time viewing from any HTML browser using any of their preferred devices (e.g., desktop, mobile, tablet). Even though radiologists typically use multiple high-resolution diagnostic displays, and referring physicians may use a single display or a mobile device, Visage 7 Live Connect is not restricted due to any potential display or device type mismatch. Instead, collaborative image viewing is optimally focused on the radiologist’s active viewer, does not require recipient users have any installed software or account(s) on Visage 7, and all recipients are able to view shared cursor movements from one or multiple screen share participants.
  • Transcatheter Aortic Valve Replacement (TAVR) Planning. Demonstrated as a works-in-progress, Visage 7 supports a new Triangle tool for TAVR planning. This tool automatically repositions all of the MPR viewers, so the axial view is in plane with the valve where the leaflets join. This rapidly allows the radiologist to drop 3 points simplifying the capture of TAVR planning measurements.
  • Visage In The Cloud – SAML. Visage 7 now natively supports the Security Assertion Markup Language (SAML) open standard for secure single-sign on (SSO) solutions with an identity provider for public cloud implementations of Visage 7.
  • Visage AI Accelerator – Iterative Learning Cycle. The Visage AI Accelerator is an end-to-end AI solution that bridges both research and diagnostic imaging with the same, unified platform. Visage will demonstrate and discuss how Visage 7 plays a central, integrated role in the AI pipeline, accelerating iterative learning and ground truth development with innovative native tools, fostering an optimized train/validate/enhance cycle.

Visage is also a proud participant in the Imaging AI in Practice (IAIP) demonstration, a multi-vendor interoperability demonstration highlighting new technologies and communications standards needed to integrate AI into the diagnostic radiology workflow. Click here to view the IAIP demonstration’s “Evolve with AI” video, found in the RSNA 2020 AI Showcase [Note: RSNA 2020 registration is required for viewing].

Visage’s virtual RSNA 2020 exhibit is available to registered attendees via this direct link. To schedule a priority virtual demonstration of Visage 7 at RSNA 2020, please click here for additional details. Experience Visage’s all-new website here.

About Visage Imaging, Inc.

A global provider of enterprise imaging solutions that enable PACS replacement with local, regional and national scale. The Visage 7 Enterprise Imaging Platform is proven, providing a fast, clinically rich, and highly scalable growth platform deliverable entirely from the cloud or on premise. Visage 7 supports the simplicity of a One Viewer™ philosophy, that enables diagnostic, clinical, specialty, research, and mobile imaging workflows from a singular platform. Visage also offers modular scalability and future-proof flexibility with enterprise workflow (Visage 7 Workflow), vendor-neutral archive (Visage 7 Open Archive) and artificial intelligence (Visage AI Accelerator) solutions, all 100% native. https://visageimaging.com 

About Pro Medicus Limited

Pro Medicus Limited [ASX: PME] is Australia’s leading imaging IT provider. Founded in 1983, the company provides a full range of integrated software products and services to hospital, imaging centers and health care groups worldwide. www.promed.com.au 

Visage, Visage Imaging, Visage Ease Pro, Visage Ease, One Viewer, ANV, and Deconstructed PACS are trademarks, registered trademarks and service marks that are licensed by Visage Imaging Inc. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective owners or licensees.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/momentum-continues-for-visage-at-rsna-2020-301181873.html

SOURCE Visage Imaging, Inc.

Webinar: AI-based Learning Market Booming

MONROE, Wash., Nov. 30, 2020 /PRNewswire-PRWeb/ — Sam will present key findings from Metaari’s new report called, “The 2021-2026 Worldwide AI-based Learning Market”. According to the report, the five-year compound annual growth rate (CAGR) for the global AI-based Learning market is a robust 32.8% and revenues will more than quadruple to $34.9 billion by 2026. The report will be available December 7, 2020 on the Serious Play Conference site.

The free webinar is being hosted by the Serious Play Conference on Wednesday, December 2nd at 7 p.m. EST4 p.m. PST.

Register Here:

https://seriousplayconf.com/sign-up-for-the-sam-adkins-webinar/

“The market conditions are very favorable for suppliers,” reports Sam S. Adkins, chief research at Metaari and author of the report. “The major revenue opportunities are in the corporate segments and the federal government agencies across the planet. The revenues are heavily concentrated in North America and the Asia Pacific. While China is the largest buying country in the Asia Pacific region, the US is the largest buying country in the world by a large margin. The most lucrative revenue opportunities are in the US throughout the forecast period.”

The demand is high and the barriers-to-entry are falling fast. Suppliers no longer have to develop expensive proprietary AI but instead “rent” AI from cloud-based AI vendors (like IBM Watson) and buy relatively inexpensive premade and pretrained components in the growing number of online marketplaces. Startups are now able to get to market very quickly.

Metaari has revised our AI-based Learning revenue forecasts significantly upward from previous forecasts. The rapid uptake of AI-based Learning coincides with the rapid evolution of AI technology in general. The competitive landscape is fundamentally different than it was a little over two years ago.

“Legacy suppliers are ‘buying their way in’ via acquisitions of AI-based Learning startups,” comments Adkins. “The major compelling pattern in the recent M&A activity is the growing number of acquisitions made by very large educational publishers and the technology giants.”

Very large education publishers like Wiley, McGraw-Hill, Pearson, Houghton Mifflin Harcourt, Daekyo, Elsevier, Follett, Cornerstone, VitalSource, and Course Hero have all acquired AI-based Learning startups in the last two years. Tech giants like Apple, Google, Medtronic, Microsoft, SAP, and IBM have scooped up AI-based Learning startups as well. These companies are tapping the massive revenues in the booming AI-based Learning market and have effectively “bought their way in”. Intense M&A activity is often a sign of consolidation but that is not the case (yet) in the global AI-based Learning market.

“Well-funded startups are coming on the market at a steady pace,” comments Adkins. “Hundreds of new AI-based Learning suppliers have entered the market since 2018. More than half (59%) of the 700 suppliers cited in this report have obtained private investment in the last two years. What is interesting is that a large number of these startups have obtained additional rounds in 2020. These are unmistakable leading indicators.”

A breathtaking $10.6 billion was invested in 406 AI-based Learning companies in 2020. Eight of the top ten funded AI-based Learning companies were US companies.

There are six sections in this report: an overview of the global market conditions, an analysis of the major catalysts driving the market, a demand side-analysis, and a supply-side analysis. There is also an appendix with Metaari’s definition of AI in general and AI-based Learning in particular and an index of over 700 suppliers.

The supply-side analysis provides five-year revenue forecast breakouts for three types of commercial AI-based Learning products and services: retail pretrained packaged AI-based Learning units, custom development services, and AI-based Learning authoring tools and platforms. Packaged content revenue is further broken out by ten content categories and platform revenues are broken out for nine distinct tool types.

About Metaari
Metaari (formerly Ambient Insight) is an ethics-based quantitative market research firm that identifies revenue opportunities for advanced learning technology suppliers. We track the learning technology markets in 126 countries. We have the most complete view of the international learning technology market in the industry. Metaari focusses solely on advanced learning technology research on products that utilize psychometrics, neuroscience, location intelligence, game mechanics, robotics, cognitive computing, artificial intelligence, virtual reality, and augmented reality.

Media Contact

Sam Adkins, Metaari, +1 360-805-4298, sam@metaari.com

 

SOURCE Metaari

Nuritas Puts Muscle Health Peptides to the Test in Human Trials

DUBLIN, Nov. 30, 2020 /PRNewswire/ — Nuritas, the world leader in artificial intelligence-based natural molecule discovery, is conducting a randomized placebo-controlled clinical trial of its first peptide ingredient, PeptiStrong™.  The new ingredient is for adults looking to preserve their vitality and youthfulness by maintaining and restoring muscle health. From our mid to late 20s, especially with modern sedentary lifestyles, we start to lose muscle. While imperceptible at first, this decreased lean mass is accompanied by a decline in function, making everyday tasks more difficult. This leads to a reduction in physical activity, a loss of independence and for some, and can lead to life-altering falls. Aside from strength, our muscle cells are metabolic powerhouses that produce most of our energy, so a decline in muscle function impacts not only strength but energy levels. With an estimated 2 Bn of the global population over 60 by 2050, the potential impact to health is substantial.

According to Prof Luc van Loon, Professor, Physiology of Exercise and Nutrition, Maastricht University, Netherlands, and an expert in muscle metabolism who is heading up the study, “If we could find effective nutritional interventions … we would have a strategy to support healthy aging for … people who want to retain muscle mass, improve metabolic health and remain active in life.”

PeptiStrong™, which enhances muscle health, was discovered in fava beans using Nuritas’s proprietary, ground-breaking AI technology, NπΦ (pronounced N-pi-fy or Nuritas Peptide Finder). The impetus for this double-blind clinical trial, which is underway (results expected by the end of 2020 due to COVID-19 delays), is the growing body of evidence described in a scientific publication documenting PeptiStrong efficacy.  The peer-reviewed article is published in Nutrients, a high-impact journal of human nutrition. The study found the peptide ingredient to ameliorate the devastating effects of disuse-induced muscle atrophy on muscle mass, at intakes indicating low human dose equivalency.

“We are proud to be proving the efficacy of our products through successful human trials. PeptiStrong™ is an important new development, and our published research and clinical trials are a testament to the tireless work of our team and the world-class quality of our in-house laboratory,” said Dr Nora Khaldi, Nuritas Founder and CEO.

Already available to consumers in the US as a dietary supplement called Elio™ Restore, PeptiStrong™ will soon be available in a large number of nutritional products and medical foods.

Professor Bruce German, Director of the University of California, Davis’s Food for Health Institute remarks on Nutrias’s contribution to food, “The significance of what Nuritas is bringing to the field of nutrition and health cannot be overstated. Not only are they using novel machine-learning approaches to go from concept to market with record-breaking speed, but they are also applying relevant pharma-level technologies such as understanding the pharmacokinetics, digestion/absorption and mechanism of action of their peptide ingredients. This is really stepping up the game.”

About NπΦ
Nuritas’s scientists use natural language processing to mine their enormous catalogue of academic research on peptide molecules, and integrate it with their own natural peptide library, the largest in the world.  Their proprietary AI predictor is then able to identify the most promising subsets of peptides based on both efficacy and bioavailability. In an iterative process, Nuritas scientists conduct in vitro lab testing of the peptides most likely to be effective, the results of which are fed back into the AI platform; a process known as machine learning.

They have submitted more than 59 national patent filings related to peptides, having secured six of these, and are working through the final stages of four others. Nuritas has brought a range of health-promoting products to market and has many more in development.

About Nuritas

Nuritas is changing the landscape of active molecule discovery by employing its proprietary artificial intelligence (AI) platform to explore vast numbers of natural sources for health transforming sustainable products.  Their technology enables Nuritas scientists to go from concept to market in less than 3 years, and accurately identify best-in-class peptides to support human, animal and plant health across multiple industries.  Nuritas has ongoing collaboration with the largest companies in the world to bring their products to life.

NURITAS is a trademark of Nuritas Limited

 

Cision View original content:http://www.prnewswire.com/news-releases/nuritas-puts-muscle-health-peptides-to-the-test-in-human-trials-301181802.html

SOURCE Nuritas

Omnilert Recognized in the Gartner 2020 Market Guide for Emergency/Mass Notification Solutions

LEESBURG, Va., Nov. 30, 2020 /PRNewswire/ — Omnilert, the innovation leader and most trusted partner in emergency communications, today announced its recognition in the Gartner “Market Guide for Emergency/Mass Notification Services Solutions,” by analysts Roberta Witty, David Gregory, Brent Predovich, Mike Gotta, published this month.  The report states that “organizations are expanding emergency or mass notification service (EMNS) use cases beyond traditional emergencies . . . to include active intruder/shooter” and “EMNS vendors are supporting these expanded use cases with . . . integration with more applications used by the organization (e.g., building access control, video surveillance, social media and digital sensors).”

The publication follows Omnilert’s recent launch of the industry’s first AI-Powered, visual gun detection solution. Omnilert Gun Detect reliably and rapidly recognizes firearms and immediately triggers multi-channel alerts and automated pre-defined safety protocols. Designed for privacy and performance, Gun Detect is a software solution typically deployed on-premise and integrated with existing IP-based video surveillance and camera systems.

In the guide, Gartner reports “Omnilert has . . . introduced an AI-based visual detection of guns by integrating with digital surveillance cameras, allowing preventive alerting to administrators and the ability to trigger automated actions.”  Existing gunshot detection technologies only work after incidents have escalated and provide vague details on the approximate location of the sound. In comparison, Omnilert Gun Detect gives emergency response teams advance warning before shots are fired, and delivers precise information on the location and visuals of the potential shooter.

“The combination of these rich capabilities provides safety teams with the broadest array of solutions, spanning prevention, notification, engagement, and management,” said Dave Fraser, Chief Executive Officer of Omnilert. “Our inclusion in Gartner’s EMNS Market Guide reaffirms Omnilert’s position as the industry’s innovation leader.” 

Omnilert Gun Detect is available today and can be implemented immediately. For more information or a demonstration, visit https://www.omnilert.com/visual-gun-detection.

Gartner Disclaimer
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Omnilert 
Founded in 2004, Omnilert was the first company to establish the emergency mass notification market. It continues to be an innovation leader and the most trusted partner to over 2,500 customers across diverse industries, including education, healthcare, manufacturing, private and public sector organizations. Omnilert offers the broadest array of solutions, spanning prevention, notification, engagement, and incident management, as well as the most comprehensive multi-channel communications. Uniquely, the organization employs automation and next-generation artificial intelligence to expedite emergency response and enable detection and visualization of critical incidents. Omnilert is privately held and headquartered outside of Washington, DC. For more information, visit Omnilert.com.

Media Contact
Alissa Vasilevskis
BOCA Communications for Omnilert
omnilert@bocacommunications.com

 

Cision View original content:http://www.prnewswire.com/news-releases/omnilert-recognized-in-the-gartner-2020-market-guide-for-emergencymass-notification-solutions-301181739.html

SOURCE Omnilert, LLC